Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Confused 2-11-16? This isn't showing up anywhere else for me
Ok, we won't hear anything about an approved patent this year. Hope I'm wrong
Did I call it or did I call it?!
Price is dropping, should get a tweet soon to help counter the fall. Been holding this forever only to see constant over promising and undelivering repeatedly $EPGL
Actually, Hardly any posts at all on Ihub. You don't have to participate on ihub to trade penny's. I just read and laugh mainly
Been playing this for 4-5 years. Was a scam when they were "buying" the weapons manufacturer, is still a scam now that they are "acquiring" someone else. On the first scam I ran 200000 shares at .02 up to .99ish. On this one I ran 1 mil share to .01ish. You can make money on scams and this most def is one you just have to know when to sell. On this rinse wash and repeat it was late last week. Mark my words, soon the "deal" will fall through and they will "litigate" with Rontan.
They need to stop angry tweeting. Tweet professionally and not act they have have the better science project at the school fair.
I believe in this company and still have all my shares but they need to stop tweeting. If you want to be a billion dollar company...act like one. Soon they will be saying Samsung released that news in a coordinated attack against them because they are scared of EPGL
Whether the deal was for a lot of money or not, you can't deny the pattern here. Misleading PRs and empty updates with no concrete info or numbers. Regardless of the current price or past performance this is indicative of the OTC. If the tech is that outstanding COO would of paid up. They are successful for a reason.
As I said yesterday I spoke with ppl at Pine Bluff, I then emailed Sooum to confirm.
Email them yourself and ask, I did.
It was the wrong sugar. I'll stake my reputation on that.
I agree with you. It was delivered but it was wrong sugar and they were given an opportunity to fix it and they didnt.your info is now out of date. It's called "Termination for Cause" or TforC. It's true. You'll see. I have 4 million shares here too...well pre split I mean.
Ask SouoM about it.
I asked around to contacts at Pine Bluff. They delivered the wrong sugar. This is 100% true. Contract was terminated for cause and Pine Bluff is getting the sugar from someone else now. Ask SouoM about it.
The real update here is them defaulting on sugar contract with government and now owe roughly 35k back to the gov. That's what happens when you deliver the wrong product...smh, what a joke of a company. Absolutely no new government contracts and there won't be after this fiasco
The "and" should of been a . space. EPGL starts new sentence.
To show good faith with the company that is "leading a giant"
I trust you but the masses don't care who you are. An email to you is not proof. EPGL disclosed patent paperwork. Let's have Cooper or one of the others put something out themselves. Why can't we get this
What "big" news though...maybe it is not as big as EPGL thinks if one of their multiple partners won't even acknowledge them.
I have my shares. Doesn't change the fact we really have nothing but their word just like any other pinky.
It's all great and they give us info but it is all really meaningless. We have this awesome super duper company working with all these giants in a field where Google is competing and talking about their partnership with Novartis...yet EPGL cannot get any of their partners to acknowledge development deals etc and we are also supposedly working with novartis..... I just don't get it. They seem just like any other pinky at the moment. Only their talk to go on.
Jeff Saturday was just on ESPN wearing what they called an Augmented Reality headset then just "AR" talking about how they use it to practice when you can't be there. Links to camera on others players helmet. Records the wearers heart rate etc.
Hy evrybodie I aim thee knew peirson en charged of EPGLs twider... I love this company but cmon guy stop drunk tweeting and not doing a spell check
I think this is just to get Google to the table as well. Here we go!!
IRVINE, Calif., Aug. 18, 2015 /PRNewswire/ -- EP Global Communications, Inc. (Public OTC: EPGL) announces a challenge to Google to confirm it is up to speed with EPGL in the smart contact lens revolution.
A year ago, Google announced with great fanfare that it had developed a smart contact lens for monitoring glucose levels. Google also announced that they possess technology for an "Autofocus" contact lens. Various executives from Google were quoted as saying that smart contact lenses could help millions of people in the future and other technology writers and industry executives have predicted a multi-billion dollar market is coming. EPGL fully agrees with Google on this point.
EPGL has several patents pending now in the smart contact lens arena, including energy harvesting technology, mass manufacturing of integrated electronics, autofocus and smart lens case technologies. EPGL has not yet publicly announced what it believes to be its most potentially valuable patents pending in the field. But perhaps most importantly, EPGL has invented solutions that will enable microelectronics to be placed into modern Silicone Hydrogel contact lenses for mass market production, without dramatically changing the current manufacturing process. This achievement is critical for the smart contact lens to truly be marketable to the masses with comfort and efficacy.
Today, EPGL is issuing a challenge to Google to update the world on their smart contact lens progress and to announce whether or not they have accomplished the same critical solutions that EPGL has mentioned above. EPGL is challenging Google to make an announcement by August 31, 2015 that it has solved for the critical Silicone Hydrogel mass market production challenges as EPGL has.
"Google is an incredible company with incredibly talented engineers and executives. We have nothing but respect for them, but we believe our little 6 cent per share company on the OTC market is likely beating a $460 billion giant in this coming revolution. We are also very talented," said Michael Hayes, President of EPGL. "We're throwing down this public challenge to see if they have truly accomplished what we have. They splashed the news a year ago now with no updates. We're doing it to show the investment community that EPGL is extremely undervalued in our opinion," Hayes continued.
Today, EPGL is also announcing that it will begin to entertain offers from various investment bankers and partners to help EPGL achieve the next level with the investment community, including higher market tiers. "We are actively seeking potential partners in what could become a very significant revenue space in the next several years; the 'Augmented Reality' or 'Bionic Vision' revolution is beginning," said Dr. David Markus, Vice President of BioMems. "We believe that EPGL will be a major player in this space going forward."
About EP Global Communications, Inc.
EP Global Communications, Inc. is an advanced technology research and development company for both medical devices and consumer electronics devices specializing in microelectronic mechanical systems (MEMS).
RELATED LINKS
Basel, Switzerland, July 15, 2014 - Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its "smart lens" technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems, provides Alcon with the opportunity to develop and commercialize Google's "smart lens" technology with the potential to transform eye care and further enhance Alcon's pipeline and global leadership in contact lenses and intraocular lenses. The transaction remains subject to anti-trust approvals.
The agreement between Google and Alcon represents an important step for Novartis, across all of its divisions, to leverage technology to manage human diseases and conditions. Google's key advances in the miniaturization of electronics complement Novartis's deep pharmaceuticals and medical device expertise. Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.
"We are looking forward to working with Google to bring together their advanced technology and our extensive knowledge of biology to meet unmet medical needs," said Novartis CEO Joseph Jimenez. "This is a key step for us to go beyond the confines of traditional disease management, starting with the eye."
"Our dream is to use the latest technology in the miniaturization of electronics to help improve the quality of life for millions of people," said Sergey Brin, Co-Founder, Google. "We are very excited to work with Novartis to make this dream come true."
Under the agreement, Google[x] and Alcon will collaborate to develop a "smart lens" that has the potential to address ocular conditions. The smart lens technology involves non-invasive sensors, microchips and other miniaturized electronics which are embedded within contact lenses. Novartis' interest in this technology is currently focused in two areas:
Helping diabetic patients manage their disease by providing a continuous, minimally invasive measurement of the body's glucose levels via a "smart contact lens" which is designed to measure tear fluid in the eye and connects wirelessly with a mobile device;
For people living with presbyopia who can no longer read without glasses, the "smart lens" has the potential to provide accommodative vision correction to help restore the eye's natural autofocus on near objects in the form of an accommodative contact lens or intraocular lens as part of the refractive cataract treatment.
The agreement marries Google's expertise in miniaturized electronics, low power chip design and microfabrication with Alcon's expertise in physiology and visual performance of the eye, clinical development and evaluation, as well as commercialization of contact and intraocular lenses. Through the collaboration, Alcon seeks to accelerate product innovation based on Google's "smart lens" technology.
"Alcon and Google have a deep and common passion for innovation," said Jeff George, Division Head of Alcon. "By combining Alcon's leadership in eye care and expertise in contact lenses and intraocular lenses with Google's innovative "smart lens" technology and groundbreaking speed in research, we aim to unlock a new frontier to jointly address the unmet medical needs of millions of eye care patients around the world."
I think this is a clear message to Cooper especially the "unless a company secures exclusivity". Going upp upp upp
Yes that's what I'm saying. I'm not planning on getting out at the moment but these updates are useless to us currently. They may not be the ordinary penny but they portray themselves that way with big talk and no backup
I don't think they should even mention deals or development agreements until the other party is ready to verify. That will shut some people up and give longs some ammo as well.
This stock is so promising but majorly dissapointing at the same time. I have a bunch tied up in this right now and it can't move...
I hope so...if this is tomorrow's news as well just through another outlet they really built us up a little to much. I'm thinking tomorrow's news will be this again and also contain something on Cooper etc. Maybe they did this today to start a compunding effect with excitement that will translate into the higher pps high they alluded to.
EPGL TWEETS 6/16/15
EPGL and CooperVision Resume Negotiations.
One day prior to a deadline set by EPGL (June 17, 2015), talks about royalties and compensation will resume. EPGL and CooperVision hold together what has potential to be key enabling technologies in the new field of bionic vision or augmented vision via electronics embedded into modern contact lenses or potentially within implantable ophthalmic devices. Important upcoming patent filing dates (the first being July 8, 2015) are a catalyst and incentive for successful negotiations to be reached soon.
Yes agreed. Paid in "the coming days"
Yes it cannot be a coincidence that it is on or right before the COO conference call. We are about to get paiiiiddd. $EPGL
Can you answer why did the company decide to go public?
There are things expected when you do this. When you go public via OTC and then don't communicate what do you expect from the flies on here? It is their money they are investing, let us know what Sooum is doing with it. When the sugar reached destination it should have been announced. That was an opportunity to follow through/up on a previous announcement and gain some faith from the shareholders.
Just getting the ticker changed would do wonders for the "faith". Pretty simple and reasonable request. Thanks though Phil for speaking up.
Have a couple good for 60 dayssell orders in at $1 and a couple at $5. Feeling good about it
Maybe we will get the update after trading today. They have done that before, give it on the day prior than thwey said after market closed
I picked up 61000 the last two days